Kiera H. Harwood

50 Flemington Rd
Parkville, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Tobramycin pharmacokinetic and pharmacodynamic targets in people with cystic fibrosis.

Tobramycin pharmacokinetic and pharmacodynamic targets in people with cystic fibrosis.

Journal: British journal of clinical pharmacology

Published: March 01, 2026

Distribution of piperacillin-tazobactam into cerebrospinal, peritoneal, and pleural fluid in children aged 0 to 18 years.

Distribution of piperacillin-tazobactam into cerebrospinal, peritoneal, and pleural fluid in children aged 0 to 18 years.

Journal: International journal of antimicrobial agents

Published: October 19, 2025

Distribution of piperacillin-tazobactam into cerebrospinal, peritoneal, and pleural fluid in children aged 0-18 years.

Distribution of piperacillin-tazobactam into cerebrospinal, peritoneal, and pleural fluid in children aged 0-18 years.

Journal: International journal of antimicrobial agents

Published: October 19, 2025

Personalized tobramycin dosing in children with cystic fibrosis: an AUC24-guided approach.

Personalized tobramycin dosing in children with cystic fibrosis: an AUC24-guided approach.

Journal: Antimicrobial agents and chemotherapy

Published: July 23, 2025

Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps.

Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps.

Journal: The Lancet regional health. Western Pacific

Published: July 01, 2025

Pharmacodynamics of Vancomycin Against Coagulase-Negative Staphylococci Bloodstream Infections.

Pharmacodynamics of Vancomycin Against Coagulase-Negative Staphylococci Bloodstream Infections.

Journal: Pharmacology research & perspectives

Published: April 01, 2025

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data and key evidence gaps.

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data and key evidence gaps.

Journal: The Lancet regional health. Western Pacific

Published: January 22, 2025

Relationship between sputum bacterial load and lung function in children with cystic fibrosis receiving tobramycin.

Relationship between sputum bacterial load and lung function in children with cystic fibrosis receiving tobramycin.

Journal: Respiratory medicine

Published: December 18, 2024

Ivacaftor Alters Macrophage and Lymphocyte Infiltration in the Lungs Following Lipopolysaccharide Exposure.

Ivacaftor Alters Macrophage and Lymphocyte Infiltration in the Lungs Following Lipopolysaccharide Exposure.

Journal: ACS pharmacology & translational science

Published: January 17, 2022

Gastrointestinal consequences of lipopolysaccharide-induced lung inflammation.

Gastrointestinal consequences of lipopolysaccharide-induced lung inflammation.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: January 11, 2022

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis.

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis.

Journal: International journal of molecular sciences

Published: June 15, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026